HaEmek Medical Center
Afula, Israel
Completed
NCT Number: NCT00593190
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
Intracameral Gas SF6 (Sulfur Hexafluoride) Injection for Acute Hydrops in Keratoconus
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Hydrops
Exclusion criteria
- Age < 18 years old
Treatment and study plan
Gas SF6 (Sulfur Hexafluoride)
DrugONCE
Primary outcomes
-
Hydrops resulotion
Time frame: weeks
Sponsors and collaborators
Lead sponsor
HaEmek Medical Center, Israel
Other
Registry information
Important dates
- Study start
- 2008
- Primary completion
- 2008
- Study completion
- 2010
- First posted
- Jan 14, 2008
- Registry last updated
- Feb 17, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.